Prevention

A new report on a measles outbreak that occurred in Ontario in 2015 emphasizes the importance of immunization in a globalized world.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Pleuromutilin antibiotics, meningococcal disease, tuberculosis, a new fluoroquinolone to treat acute bacterial skin and skin structure infections, and WHO’s position on HPV vaccine recommendations makes up this week’s Top 5 articles.

Belinda Ostrowsky, MD, MPH, explains how to treat patients who expect to receive an antibiotic, but should not.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

A new Johns Hopkins study finds that one fifth of hospitalized adults experience adverse effects from prescribed antibiotics; one fifth of those effects occurred in patients who should not have been prescribed antibiotics in the first place.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.

An infection control intervention coming from the VHA resulted in a significant reduction of MRSA in veteran living centers.

Seniors are at increased risk of hepatitis B, hepatitis C, and HIV. Prevention and early detection of potential infection are critical to avoiding long-term impact.

Genovefa Papanicolaou, MD, discusses a new antiviral in development to prevent cytomegalovirus.

Otto Schwake, PhD, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

WHO releases recommendations regarding HPV vaccination as primary preventive intervention against cervical cancer.

Gonzalo Bearman, MD, MPH, explains what is known about Clostridium difficile prevention and control.

Researchers discover a new approach for measuring how long it takes an antibiotic to kill bacteria.

Commentary authors warn that lack of access to antibiotics to treat common bacterial infections are becoming difficult to access due to manufacturers finding them less profitable to produce and market; this can have serious implications.

Researchers from Yale University have come up with a new “chemical process” that may aid in the development of a new class of antibiotics.

Badela, a new antibiotic developed by Melinta Therapeutics, was just approved by the US FDA to treat acute bacterial skin and skin structure infections.

Milena McLaughlin, PharmD, MSc, explains the different ways that antimicrobial shortages can impact patient care.

The CDC examines the high incidence of meningococcal disease in the “meningitis belt,” found within sub-Saharan Africa, and the efforts of the Meningitis Vaccine Project to monitor the impact of a meningococcal A conjugate vaccine.

Lauri A. Hicks, DO, discusses the use of immunotherapy in tackling antibiotic resistance.

Snigdha Vallabhaneni, MD, MPH, discusses the keys to controlling the spread of Candida auris.

New drugs for HIV, the growing rate of antibiotic resistance, a new hepatitis C treatment option, and updates on the Ebola outbreak and Lyme disease diagnostics, make up the Top 5 articles for this week.

Lillian Abbo, MD, shares key elements that clinicians should incorporate into antimicrobial stewardship practices.

Jeremy Burrows, DPhil, MA, explains how new antimalarials could change the game for countries where malaria is endemic.